Freenome

Decision/Risk Analysis · Brisbane, CA · Founded 2014 · Privately Held (backing)

Developer of a multi-omics platform designed to detect cancer at an early stage through a routine blood draw. Freenome is based in Brisbane, CA and was founded in 2014. It is valued at about $2.2 billion as of Oct 2026, set by institutional fund marks. It has raised $1.4 billion across 3 recorded rounds; the latest was a $240 million pipe round in Dec 2025.

PMV mark · valuation
$2.2B
Oct 2026
Priced at
—
Total raised
$1.4B
Last round
PIPE
Dec 2025
Cap table — not yet on record

Freenome's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Pro
The prices on Freenome
  • ·29 fund marks: filer, period, implied $/share
Pro · $99 a month
List $299 · founding price, locked for as long as you stay

Membership and data by Private Market View

Frequently asked about Freenome

Where does Freenome's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Freenome's 3 recorded funding rounds.